Curriculum Vitae
Name: Waseem Tamim
Y. Hamoudi
Date & Place
of Birth:
Kuwait /
Ahmadi 25th Nov., 1965.
Nationality:
Jordanian
Status:
Married
with two children
Permanent Address:
Amman, Jordan
P.O Box 922720 Amman 11192 Tel: 079-5723273
E-mail:
waseem6520012001@yahoo.com
Scientific Degrees
Ø
Consultant in Gastroenterology & Hepatology,
Ministry of health and Jordan Medical Council, 2011.
Ø
Jordanian Medical Council Board for the specialty of
gastroenterology & Hepatology, Amman
1998.
Ø
European Board of Gastroenterology March 1998.
Ø
Specialist in Internal Medicine, Gastroenterology &
Hepatology, University of Medicine and Pharmacology
– Cluj -Napoca; Romania, March 3rd
1998.
Training period 1991 – 1998.
Ø
Specialist in Internal Medicine, University of
Medicine and Pharmacology – Cluj
- Napoca, Romania at 1994. Training period
1991-1994.
Ø
Diploma of doctor of medicine (M.D.) General
Medicine, 1991. Study period 1985 – 1991.
University of Medicine and Pharmacology, Cluj
Napoca, Romania.
.
Ø
General Secondary Education Certificate in May 1983,
Ahmadi Secondary School, Kuwait, Scientific Section.
Scientific Experience
Ø
Special Training course in Detection and Treatment
of Early Gastrointestinal Cancer and Related Tumors.
Tokyo - Japan, from January 10, 2002 to March 5,
2002.
Ø
Special Training course in Advanced Therapeutic
Endoscopic Retrograde Cholangio- Pancreatography
(ERCP) at the Royal Medical Services, Al Hussein
Medical Center, Amman – Jordan,
2004-2005.
Ø
Training in Advanced Therapeutic Endoscopy at
Tokushukai Medical Corporation, Japan,
2005.
Ø
Special training course in advanced Gastrointestinal
stenting course and workshop- European Endoscopy
Training Centers- Rome –Unversita Cattolica del
Sacro Cuore ,2006
Ø
Special Training Course on Liver transplantation –
Royal Free Hospital, Hampstead, London, 2009
Ø
Good
clinical practice (GCP) training workshop for
investigators, Amman- 2010 Jordan.
Ø
Lecturer at the Al-Balqa Applied Science University
- Rufaida Nursing & Para- medical Faculty
(Physiology and Pathophysiology)
2004-2015.
Ø
Clinical Associate Professor at Mouta University
–Faculty of Medicine
–Internal Medicine-
2007-2009.
Ø
Clinical Associate Professor at Jordan University
Hospital – Faculty of Medicine – Internal Medicine-
2012-2016.
Ø
Member
and Examiner of the Jordan Medical Council-
Jordanian Board of Gastroenterology since 2010-
2017.
Ø
Member of the Jordanian National Consensus comity
for hepatitis B and C (2010-2016)
Ø
Member
of the Jordanian National committee for HIV/AIDS.
Ø
Member
of the Jordanian National Committee for Malaria.
Ø
Member of the Global Guidelines Committee of the
World Gastroenterology Organization (WGO)
2013-2015.
Ø
Member of the Hepatology Interest Group of the world
Gastroenterology Organization (WGO)
2013-2017.
Ø
Member
of the e-WGN Editorial Board (World Gastroenterology
Organization e- Journal)
2015-2017
Ø
Committee member of the world digestive health
(viral hepatitis). The world gastroenterology
organization (WGO).
Ø
Committee member of the Jordanian FDA (Food and drug
Administration), 2010- 2014 - Pricing comity and
2016-2019 New medicine registration
comity..
Ø
Member
of the panel expert (working group) for the
Management of precancerous conditions and lesions in
the stomach (MAPS) - the European Society of
Gastrointestinal Endoscopy (ESGE).
Ø
Head of Internal Medicine Department – Al Bashir
Teaching Hospital, 2012- 2016.
Ø
Board
Member of the Ministry of Health Ethical comity for
research
2012-2016.
Ø
Board
Member of the Electronic Library of Medicine (ELM)
2012-2017.
Ø
Member
of the editorial board of the Clujul Medical
Journal.
Ø
Member
of the Royal Medical Services Medical Journal
editorial board and AJMR.
Ø
Member
of the editorial board of Journal of Hepatitis
Research.
Ø
Member
of the editorial board of the e journal world
gastroenterology organization.
Ø
Secretary General of the Jordanian Society of
Gastroenterology & Hepatology 2008-2010, 2010-2012,
2012-2014 and
2014-2017.
Memberships
Ø
Member of the European Association of
Gastroenterology and Endoscopy (EAGE).
Ø
Member of the European Association for the Study of
the Liver (EASL).
Ø
Member of the European society for gastrointestinal
endoscopy (ESGE).
Ø
Member of the Romanian Society of
Gastroenterology.
Ø
Member
of the Jordan Medical Association.
Ø
Member
of the Jordanian Friends of Liver patients Society.
Ø
Member
of the Jordanian friends of celiac disease patient’s
charity
association.
Published Studies
1)
Is there an association between Coronary Heart
disease and Colorectal Carcinoma? Romanian Journal
of Gastroenterology Vol. 6 No.1 March,
1997.
2)
Endoscopic Band Ligation Compared with Sclerotherapy
for Treatment of Esophageal Variceal Bleeding.
Romanian Journal of Gastroenterology Vol. 6,
supplement 1 June 1997.
3)
Prevalence of Helicobacter Pylori (HP) infection in
the General Population of NW Romania. Romanian
Journal of Gastroenterology Vol. 6, supplement 1;
June 1997.
4)
Epidemiological and Clinical Features of CROHN’s
disease in the region of Transylvania - Romania.
Fifth International Symposium on Inflammatory Bowel
Disease .Falk Symposium No. 101, Jerusalem, Sept.
22nd – 24th,
1997.
5)
Choledocho-Colonic Fistula in an Elderly Patient. A
Case Report. Romanian Journal of gastroenterology
Vol. 7 No. 2 – June
1998.
6)
Gastric and Gallbladder Hypo responsiveness to an
exogenous nitric oxide donor in patients with
advances liver cirrhosis. The American Journal of
Gastroenterology, Vol. 94 No. 1999.
7)
Inflammatory Bowel Disease by colonoscopy –
Retrospective study 1996-2000- Al Bashir Hospital
Experience. The 2nd Pan Arab Conference & 7th
Jordanian Internal Medicine Conference, Amman-Jordan
25-29th April
2004.
8)
Colorectal Carcinoma by colonoscopy in
Jordan-Retrospective study 1996-2000- Al Bashir
Hospital Experience. The 2nd Pan Arab Conference&
7th Jordanian Internal Medicine Conference,
Amman-Jordan 25-29th April
2004.
9)
Incidence of pediatric patients diagnosed as
inflammatory bowel disease by colonoscopy in Jordan.
The 4th Jordanian Hispanic medical congress. Amman-
Jordan 31march – 2 April
2005.
10)
Jordan
and Hepatitis B Virus, Do We Have to Worry? World
gastroenterology news. Vol. 1; May
2007-11.
11)
Percutaneous blinded liver biopsy, safety,
importance and impact on treatment. The
International Congress on liver Diseases & liver
Transplantation. 03-04 March 2009 King Faisal
Specialist Hospital & research center, Riyadh,
Kingdom of Saudi Arabia.
12)
Thalassemia and hepatitis C treatment in Jordan.
Middle East & Africa Summit on Hepatitis. 20-21
November 2008, Dubai, United Arab of
Emirates.
13)
Jordan National Consensus on Viral Hepatitis B & C
2010. Book –MOH- Directorate of communicable disease
/Jordan.
14)
Management of precancerous conditions and lesions in
the stomach (MAPS): guideline from the European
Society of Gastrointestinal Endoscopy (ESGE).Endoscopy
2012; 44:
74–94.
15)
HCV
infection prevalence in a population recruited at
health centers in Jordan.
Journal of Epidemiology and Global Health; March
2013,vol.3,No.1
16)
Durability of sustained virological response and
long term follow up to Pegylated Interferon and
Ribavirin in patients with hepatitis C. Hepatol Int
(2013) 7 (Suppl 1): S1-S754.
17)
National Malaria Management Guidelines 2nd
edition 2013.Book. Ministry of health. Directorate
of communicable disease.
www.moh.gov.jo
18)
Endoscopic Mucosal Resection (EMR) for colonic
difficult sessile polyps and early superficial
colonic tumors, an alternative effective method to
colonic surgery. A Middle Eastern country
experience. Scripta Scientifica Medica,vol.45,S
2,2013;35-39
19)
Classification and Coding Manual for Disposables
Consumables and Medical Supplies. Book - Ministry of
Health 2014.
www.moh.gov.jo
20)
Pegylated Interferon Alfa 2a Treatment in Patients
with Chronic Hepatitis B and Genotype D in Jordan. J
hepat Res-Vol.1 issue 2-2014 ISSN:
2381-9057
21)
Global
prevalence and genotype distribution of hepatitis C
virus infection in 2015: A Modeling study. The
Lancet December 2016 Doi 10.1016/s2468-
1253(16)30181-9
22)
Frequency of Three Common Mutations of CARD15/NOD2
Gene in Jordanian Patients with Crohn’s Disease.
British Journal of Medicine & Medical Research 7(2):
93-105,
2015
23)
A
Multicenter, Prospective, Observational,
Non-Interventional Cohort Study Evaluating
On-Treatment Predictors of Response in Subjects with
HBeAg positive or HBeAg negative Chronic Hepatitis B
Receiving Therapy with PEGASYS® (Peginterferon
alfa-2a 40KD). Journal of Hepatology;
2016
24)
Jordan
National strategy for diagnosing and treating
Hepatitis B & C 2016. Book, MOH- Directorate of
communicable disease
/Jordan
25)
Hepatitis B genotypic and serologic characteristics
in Jordan. JRMS Dec 2016;
23(4):17-22/DOI:10.12816/0032196
26)
Irritable bowel syndrome in Jordan. eWGN -feb
2017-Vol
1;14-15
27)
Textbook of Hepatogastroenterology. ERCP chapter.
2017
28)
A
new hereditary colorectal cancer network in the
Middle East and eastern mediterranean countries to
improve care for high-risk families. Familial
cancer. 2017;
DOI:
10.1007/s10689-017-0018-6
Languages
·
Arabic
- English - Romanian
(Excellent)
·
French (Acceptable).
Actual Working
Place
Royal Hospital – Private Gastroenterology &
Hepatology clinic
Previous
working Places
·
Al Bashir Hospital – Gastroenterology-Hepatology
Unit - Amman - Jordan. 1999, as a Consultant in
gastroenterology and Hepatology.
·
Head of Internal Medicine Department – Al Bashir
Hospital – Amman-Jordan 2012-
2016.
·
Prince Hamza Hospital-
Gastroenterology-Hepatology unit 2006-2008,
as specialist gastroenterology
&Hepatology.
·
Al
Hussein Medical Centre, Royal Medical Services –
Endoscopy Unit- 2004- 2005.
·
Al
Karak Teaching Hospital, Endoscopy
unit, 2005-2007, part time
gastroenterology.
Personal
Abilities
Ø
Upper
Diagnostic Endoscopy.
Ø
Upper
Therapeutic Endoscopy, INCLUDING:
n SCLEROTHERAPY
AND BAND LIGATION FOR BLEEDING
ESOPHAGIAL VARICES,
n POLYPECTOMY
n HEMOSTASIS TECHNIQUES OF THE UPPER G.I.
TRACT,
n DILATATION OF ESOPHAGEAL STENOSIS,
ACHALASIA, PNEUMATIC AND HYDROSTATIC DILATATION,
n FOREIGN BODY
EXTRACTION.
n STENTING OF ESOPHAGEAL CANCERS.
n MUCOSECTOMY (EMR).
Ø
Lower
Diagnostic Endoscopy (TOTAL COLONOSCOPY).
Ø
Therapeutic Colonoscopy, INCLUDING:
n POLYPCTOMY
n HEMOSTATIC TECHNIQUES OF THE LOWER
G.I.TRACT.
n
Stenting of colonic strictures.
n
Dilatation of colonic stricture.
n
MUCOSECTOMY (EMR).
Ø
DIAGNOSTIC
ENDOSCOPIC RETROGRADE CHOLANGIO- PANCREATOGRAPHY (ERCP)
Ø
THERAPEUTIC ENDOSCOPIC RETROGRADE
CHOLANGIO-
PANCREATOGRAPHY-ERCP: including stones removal,
stricture dilatation, and stent insertion.
Ø
Per
Cutanous Endoscopic Gastrostomy (PEG)
Ø
ABDOMINAL
ULTRASONOGRAPHY.
Ø
Percutaneous Liver Biopsy:
-
Blinded -
Menghini.
-
Ultrasonic
guided liver
biopsy.
|